Atlas FDA

SynchroMed® Infusion System

FDA premarket approval P860004/S373 · decided 2021-05-04

Approval details

PMA number
P860004
Supplement
S373
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SynchroMed® Infusion System
Generic name
Pump, infusion, implanted, programmable
Applicant
Medtronic, Inc.
Date received
2021-04-09
Decision date
2021-05-04
Days to decision
25 days
Decision code
OK30
Product code
LKK
Advisory committee
General Hospital
Expedited review
No
Location
Minneapolis, MN
Statement
Implementation of additional detection controls for the pump tube O-ring assembly processes for the SynchroMed Infusion System and the Implantable System for Remodulin.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19